Evidence map›Paper›PMID 41214228›Full record

ReviewArchives of virology2025

NK and T cell evasion mechanism of human cytomegalovirus.

Animesh Sarker, Joynab Binta Arafat

Abstract readReview
PubMed Publisher
In one paragraph

Review in Archives of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Mechanisms and Determinants of CMV Reactivation in Kidney Transplantation.International journal of molecular sciences · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Animesh SarkerDepartment of Biotechnology and Genetic Engineering, Mawlana Bhashani Science and Technology University, Santosh, Tangail, 1902, Bangladesh. animesh@mbstu.ac.bd.ORCID http://orcid.org/0009-0005-7576-8932
Joynab Binta ArafatDepartment of Biotechnology and Genetic Engineering, Mawlana Bhashani Science and Technology University, Santosh, Tangail, 1902, Bangladesh.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human cytomegalovirus (HCMV) is a betaherpesvirus that has evolved multiple defense mechanisms against host immunity. Most HCMV infections go unnoticed, but the reactivation of the latent virus can be life-threatening in immune-suppressed people. Over millions of years of coevolution with the human host, HCMV has adapted to evade both innate and adaptive immune responses through a dynamic host-pathogen arms race in which selective pressures from host immunity have driven the diversification and refinement of viral genes. This is particularly evident in the UL and US regions of the HCMV genome, which encode multiple proteins that interfere with antigen presentation and modulate immune receptor signaling. HCMV also employs molecular mimicry, encoding an MHC class I homolog, UL18, which binds to LIR-1 to inhibit NK cell activation, enabling immune evasion and persistent infection. This mini-review focuses on the key immunoevasive mechanisms by which HCMV gene products interfere with NK and T cell recognition and effector functions to modulate host immune responses. Elucidating these strategies is critical for identifying novel antiviral targets and informing the rational design of effective vaccines.

Indexed as

CytomegalovirusCytomegalovirus InfectionsImmune EvasionKiller Cells, NaturalT-LymphocytesHost-Pathogen InteractionsHumansViral ProteinsViral ProteinsApoptosisCytokine signalingCytotoxic T cellHCMVImmune evasionNK cell

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.